RBFC
MRK icon

Roman Butler Fullerton & Co’s Merck MRK Stock Holding History

Roman Butler Fullerton & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
8,451
+54
+0.6% +$6.23K 0.29% 92
2025
Q4 		$917K Sell
8,397
-83
-1% -$7.79K 0.24% 108
2025
Q3 		$734K Sell
8,480
-112
-1% -$9.22K 0.2% 121
2025
Q2 		$728K Sell
8,592
-1,103
-11% -$87.7K 0.21% 118
2025
Q1 		$760K Sell
9,695
-494
-5% -$46.1K 0.3% 83
2024
Q4 		$998K Sell
10,189
-759
-7% -$78.2K 0.32% 80
2024
Q3 		$1.22M Buy
10,948
+295
+3% +$35K 0.37% 70
2024
Q2 		$1.36M Sell
10,653
-570
-5% -$73.4K 0.44% 56
2024
Q1 		$1.42M Sell
11,223
-188
-2% -$23.2K 0.53% 49
2023
Q4 		$1.38M Sell
11,411
-67
-0.6% -$6.96K 0.54% 48
2023
Q3 		$1.19M Sell
11,478
-621
-5% -$66.9K 0.56% 49
2023
Q2 		$1.28M Sell
12,099
-2,517
-17% -$286K 0.59% 50
2023
Q1 		$1.7M Buy
14,616
+2,016
+16% +$218K 0.85% 25
2022
Q4 		$1.39M Buy
12,600
+1,074
+9% +$110K 0.72% 37
2022
Q3 		$1.05M Buy
11,526
+46
+0.4% +$4.11K 0.67% 44
2022
Q2 		$1.09M Buy
11,480
+89
+0.8% +$7.89K 0.61% 46
2022
Q1 		$935K Buy
11,391
+49
+0.4% +$3.86K 0.43% 72
2021
Q4 		$869K Buy
11,342
+300
+3% +$23.9K 0.38% 77
2021
Q3 		$852K Buy
11,042
+15
+0.1% +$1.14K 0.4% 75
2021
Q2 		$858K Sell
11,027
-540
-5% -$40.2K 0.42% 77
2021
Q1 		$846K Sell
11,567
-3,158
-21% -$233K 0.42% 80
2020
Q4 		$1.15M Sell
14,725
-1,149
-7% -$87.9K 0.68% 47
2020
Q3 		$1.26M Sell
15,874
-457
-3% -$35.8K 0.82% 34
2020
Q2 		$1.21M Buy
+16,331
New +$1.23M 0.86% 32
2020
Q1 		– Sell
-18,747
Closed -$1.63M – 159
2019
Q4 		$1.63M Sell
18,747
-437
-2% -$35.9K 1.07% 22
2019
Q3 		$1.54M Sell
19,184
-256
-1% -$20.5K 1.07% 20
2019
Q2 		$1.55M Buy
19,440
+121
+0.6% +$9.27K 1.04% 21
2019
Q1 		$1.53M Buy
19,319
+4,924
+34% +$368K 1.07% 19
2018
Q4 		$1.02M Buy
+14,395
New +$1.02M 0.87% 26

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Roman Butler Fullerton & Co's MRK Position: Q1 2026 in Review

Roman Butler Fullerton & Co increased its Merck (MRK) stake by 0.64% in Q1 2026, buying an estimated $6.23K and bringing the position to 8,451 shares worth $1.04M. The position accounts for 0.29% of the portfolio, ranked #92.

Roman Butler Fullerton & Co first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.7M in Q1 2023. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Roman Butler Fullerton & Co held 8,451 shares of Merck worth $1.04M as of Q1 2026.
  • Roman Butler Fullerton & Co bought 54 Merck shares in Q1 2026, an estimated $6.23K.
  • Merck made up 0.29% of Roman Butler Fullerton & Co's portfolio in Q1 2026, its #92 holding.
  • Roman Butler Fullerton & Co first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
  • Roman Butler Fullerton & Co's Merck position peaked at $1.7M in Q1 2023.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q1 2026, filed 30 Apr 2026.